Over the last three decades, the diseases such as the cardiovascular, urological, and neurological disorders have surpassed cancer as the leading cause of death and morbidity worldwide. According to Department of Health figures from 2015, more than 40 percent of New York adults have a chronic ailment, and chronic diseases account for 23 percent of all hospitalizations in the state. Consequently, the market is expected to be driven by an increase in the use of peripheral intravenous catheters in the treatment of chronic disorders that lead to hospitalization within the forecasted period.